Ashurst is advising Acacia Pharma on its £15 million fundraising led by Fidelity Biosciences and Novo A/S. Existing shareholders Gilde Healthcare and Lundbeckfond Ventures are also participating.

The Ashurst team is led by corporate partner Anthony Clare, assisted by associate Kit Westropp.